+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hematology Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5231091
  • Report
  • December 2020
  • Region: Global
  • 79 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • ARUP Laboratories
  • Biosurfit, SA
  • ET Healthcare Inc
  • Group K Diagnostics
  • Ohio State University
  • PortaScience Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Hematology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hematology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hematology tests include various blood tests that help diagnose and monitor various conditions. It includes the sub-segments Complete Blood Count (CBC) Tests, Hemoglobin Laboratory Tests, Hemoglobin Point of Care (POC) Tests, Hematocrit Point of Care (POC) Tests, Hemoglobin & Hematocrit POC Tests, Erythrocytes Point of Care (POC) Tests, White Blood Count Point of Care (POC) Tests and Platelets Point of Care (POC) Tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hematology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hematology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hematology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ARUP Laboratories
  • Biosurfit, SA
  • ET Healthcare Inc
  • Group K Diagnostics
  • Ohio State University
  • PortaScience Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Hematology Tests Overview

3 Products under Development
3.1 Hematology Tests - Pipeline Products by Stage of Development
3.2 Hematology Tests - Pipeline Products by Segment
3.3 Hematology Tests - Pipeline Products by Territory
3.4 Hematology Tests - Pipeline Products by Regulatory Path
3.5 Hematology Tests - Pipeline Products by Estimated Approval Date

4 Hematology Tests - Pipeline Products under Development by Companies
4.1 Hematology Tests Companies - Pipeline Products by Stage of Development
4.2 Hematology Tests - Pipeline Products by Stage of Development

5 Hematology Tests Companies and Product Overview
5.1 Aptitude Medical Systems Inc Company Overview
5.1.1 Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 ARUP Laboratories Company Overview
5.2.1 ARUP Laboratories Pipeline Products & Ongoing Clinical Trials Overview
5.3 BioMedomics Inc Company Overview
5.3.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biosurfit, SA Company Overview
5.4.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 DxDiscovery Inc Company Overview
5.5.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Dynasil Corporation of America Company Overview
5.6.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
5.7 ET Healthcare Inc Company Overview
5.7.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 genedrive plc Company Overview
5.8.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Group K Diagnostics Company Overview
5.9.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.10 hemCheck Sweden AB Company Overview
5.10.1 hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
5.11 Ohio State University Company Overview
5.11.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Optolane Technologies Inc Company Overview
5.12.1 Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 PortaScience Inc Company Overview
5.13.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Retham Technologies LLC Company Overview
5.14.1 Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Sanguina LLC Company Overview
5.15.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Siemens Healthcare Diagnostics Inc Company Overview
5.16.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Silver Lake Research Corporation Company Overview
5.17.1 Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.18 T2 Biosystems Inc Company Overview
5.18.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Melbourne Company Overview
5.19.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
5.20 VitaMe Technologies Inc Company Overview
5.20.1 VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hematology Tests- Recent Developments
6.1 Jun 17, 2020: Sysmex launches flow cytometer XF-1600 in North America
6.2 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.3 May 02, 2020: Halo provides operational update
6.4 Feb 20, 2020: FDA files ARUP Laboratories' AAV5 CDx for hemophilia A gene therapy treatment
6.5 Feb 20, 2020: BioMarin's Biologics license application for valoctocogene roxaparvovec accepted for priority review by FDA with review action date of August 21, 2020
6.6 Feb 19, 2020: Biohit Group financial statement release 2019
6.7 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
6.8 Feb 12, 2020: Halo announces promotion of Katie Field to President of Halo and provides Bophelo Bioscience update
6.9 Feb 12, 2020: Quidel reports fourth quarter and full year 2019 financial results
6.10 Feb 07, 2020: User survey at Capio S:t Göran’s hospital show 100% support from participating staff for Hemcheck’s product concept
6.11 Feb 04, 2020: T2 Biosystems announces participation at Clinical Conferences in February
6.12 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
6.13 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.14 Jan 15, 2020: Accellix announces the appointment of Nir Nimrodi as chairman and chief executive officer
6.15 Jan 11, 2020: Study completed at Capio S:t Goran’s hospital showing significantly lower frequency of hemolysed blood samples at the emergency care unit when using Hemcheck’s product concept
6.16 Jan 09, 2020: Quidel announces preliminary revenue for fourth quarter 2019
6.17 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
6.18 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents
6.19 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
6.20 Dec 11, 2019: Medica 2019 World Forum of Medicine
6.21 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
6.22 Dec 05, 2019: Akers Biosciences continues strategic review; explores leveraging its 30-years of laboratory operations to enter into the hemp and minor cannabinoid processing industry
6.23 Dec 03, 2019: Consort Medical: Interim results of 2019

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Hematology Tests - Pipeline Products by Stage of Development
Table 2: Hematology Tests - Pipeline Products by Segment
Table 3: Hematology Tests - Pipeline Products by Territory
Table 4: Hematology Tests - Pipeline Products by Regulatory Path
Table 5: Hematology Tests - Pipeline Products by Estimated Approval Date
Table 6: Hematology Tests Companies - Pipeline Products by Stage of Development
Table 7: Hematology Tests - Pipeline Products by Stage of Development
Table 8: Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: POC Test - Trauma Coagulopathy - Product Status
Table 10: POC Test - Trauma Coagulopathy - Product Description
Table 11: ARUP Laboratories Pipeline Products & Ongoing Clinical Trials Overview
Table 12: AAV5 Total Antibody Assay - Product Status
Table 13: AAV5 Total Antibody Assay - Product Description
Table 14: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Fetomaternal Hemorrhage Test - Product Status
Table 16: Fetomaternal Hemorrhage Test - Product Description
Table 17: Hemo SCAN - Product Status
Table 18: Hemo SCAN - Product Description
Table 19: Hemo SCAN S - Product Status
Table 20: Hemo SCAN S - Product Description
Table 21: Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Status
Table 22: Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Description
Table 23: Sickle SCAN - Product Status
Table 24: Sickle SCAN - Product Description
Table 25: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Spinit Device - Blood Quantitation Anemia Assay - Product Status
Table 27: Spinit Device - Blood Quantitation Anemia Assay - Product Description
Table 28: Spinit Device - Thrombocytopenia Assay - Product Status
Table 29: Spinit Device - Thrombocytopenia Assay - Product Description
Table 30: DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Diagnostic Assay - Sickle Cell Disease - Product Status
Table 32: Diagnostic Assay - Sickle Cell Disease - Product Description
Table 33: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Test - Hemophilia - Product Status
Table 35: Diagnostic Test - Hemophilia - Product Description
Table 36: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Pylon Assay - D-Dimer - Product Status
Table 38: Pylon Assay - D-Dimer - Product Description
Table 39: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Genedrive - Factor V Leiden - Product Status
Table 41: Genedrive - Factor V Leiden - Product Description
Table 42: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 43: KromaHealth Kit - Complete Blood Count - Product Status
Table 44: KromaHealth Kit - Complete Blood Count - Product Description
Table 45: hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
Table 46: v-Test - Serum Tubes - Product Status
Table 47: v-Test - Serum Tubes - Product Description
Table 48: Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Diagnostic Assay - Thrombotic Thrombocytopenic Purpura - Product Status
Table 50: Diagnostic Assay - Thrombotic Thrombocytopenic Purpura - Product Description

List of Figures
Figure 1: Hematology Tests - Pipeline Products by Stage of Development
Figure 2: Hematology Tests - Pipeline Products by Segment
Figure 3: Hematology Tests - Pipeline Products by Territory
Figure 4: Hematology Tests - Pipeline Products by Regulatory Path
Figure 5: Hematology Tests - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
3 of 3
  • Aptitude Medical Systems Inc
  • ARUP Laboratories
  • BioMedomics Inc
  • Biosurfit, SA
  • DxDiscovery Inc
  • Dynasil Corporation of America
  • ET Healthcare Inc
  • genedrive plc
  • Group K Diagnostics
  • hemCheck Sweden AB
  • Ohio State University
  • Optolane Technologies Inc
  • PortaScience Inc
  • Retham Technologies LLC
  • Sanguina LLC
  • Siemens Healthcare Diagnostics Inc
  • Silver Lake Research Corporation
  • T2 Biosystems Inc
  • University of Melbourne
  • VitaMe Technologies Inc
Note: Product cover images may vary from those shown
Adroll
adroll